An audit of the detection of trisomy 18 in prenatal screening for Down syndrome using the Combined test

Prenatal Diagnosis

Volumn 31, Issue 13, 2011, Pages 1317-

  Huttly, Wayne J ^a   Wald, Nicholas J ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Combined test; Down syndrome; Edwards syndrome; Maternal serum screening; Prenatal screening; Trisomy 18

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ALGORITHM; DOWN SYNDROME; FEMALE; FETUS DEATH; HIGH RISK POPULATION; HUMAN; LETTER; LIVE BIRTH; MAJOR CLINICAL STUDY; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY OUTCOME; PREGNANCY TERMINATION; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; TRIPLOIDY; TRISOMY 13; TRISOMY 18; TRISOMY 21;

ALGORITHMS; DOWN SYNDROME; FEMALE; HUMANS; MEDICAL AUDIT; PREGNANCY; PRENATAL DIAGNOSIS; RISK ASSESSMENT;

EID: 82255175568     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2890     Document Type: Letter

References (2)

1. Palomaki G, Knight G, Neveux L, Pandian R, Haddow J. 2004. Maternal serum invasive trophoblast antigen (ITA) in first trimester trisomy 18 pregnancies, Poster 2794 presented at The American Society for Human Genetics Annual Meeting, 2004, Toronto.
2. Tul N, Spencer K, Noble P, et al. 1999. Screening for trisomy 18 by fetal nuchal translucency and maternal serum free ß-hCG and PAPP-A at 10-14weeks of gestation. Prenat Diagn 19: 1035-1042.